Skip to content
logo

Leaders in Minimally Invasive Spine Surgery

Join a Clinical Trial of a Treatment for Neck Pain

Research

The Anand Spine Group is participating in an Investigational Device Exemption study – monitored by the Food and Drug Administration (FDA) and sponsored by Centinel Spine, LLC – comparing the prodisc C Vivo and prodisc C SK devices with an FDA-approved Total Disc Replacement device in order to validate their safety and effectiveness for the treatment of two-level symptomatic cervical disc disease (SCDD). Contact The Anand Spine Group at (310) 423-9779 to make an appointment to see if you are eligible.  

Scroll To Top